The lowest quote is usually the most expensive decision

In 2025, the cheapest face cleanser quote in your inbox is almost always the most expensive decision sitting on your desk. Not because cheap suppliers are dishonest — some of them are perfectly good. Because the number on the quote is not the number you pay.

I'm a procurement manager at a 130-person beauty company. I've owned our contract manufacturing budget — roughly $2.4 million a year — for six years, negotiated with over 40 vendors, and logged every purchase order in our cost tracking system. I mention that only so you know where the numbers below come from.

Face cleanser sourcing has changed more in the last three years than in the ten before it. In 2019 my vendor comparison was basically three columns: unit price, MOQ, lead time. That was the whole spreadsheet. If that's still your spreadsheet today, you're pricing maybe 60% of what you're actually buying.

Argument 1: The unit price is a small fraction of the total

In 2023 I ran a total-cost comparison on two quotes for a hydrating facial cleanser. Supplier A came in at $2.10 per unit, 5,000 MOQ. Supplier B quoted $1.78. On paper, B saved us around $1,600 on the run — enough that my manager asked why I hadn't signed yet.

Then I added the things B billed separately: $600 setup, $450 for stability testing that A included, six cents a unit for a pump A bundled into the price, and roughly 3% more on freight because B ships from a different port. Real difference between the two: about $140.

For $140, I would have taken on a supplier who answered emails two weeks slower and had no documented preservative challenge test in their file. That's not a saving. That's a discount on risk I hadn't priced yet.

So now the line items I actually compare look like this:

  • Base formula cost per unit, at our real annual volume, not the MOQ
  • Setup, tooling, and plate charges (one-time, but they hit the P&L)
  • Stability and compatibility testing — included or invoiced?
  • Packaging: pump, cap, label application, who supplies what
  • Freight, duties, and the incoterm hiding behind "FOB"
  • Reformulation and reprint exposure if a claim fails

Four of those six don't show up on the quote at all. That's the whole problem.

Argument 2: Five skin types from five "cheapest" vendors costs more than five from one

Here's the part that surprises people. I went back and forth on this for most of a quarter before I believed my own numbers.

Most brands in this category aren't buying one cleanser. They're buying a gentle face cleanser, a face cleanser for men, something for sensitive skin, an oil face cleanser, and a hydrating formula. Five lines, five specs, five claim sets.

The instinct is to source each one from whoever quotes lowest on that SKU. I did that for two years. Then I added up what it actually cost us: five stability protocols instead of one, five sets of packaging specs, five QA audits, freight split across five shipments, and five MOQ commitments eating working capital at once.

When we consolidated to one partner that could cover all five skin types, the blended unit price went up about 8%. Total annual spend went down roughly 14%. Not a rounding error.

That's before counting the soft costs — the account manager who understood our brand voice, the reformulation we didn't have to do because their base system already worked across three of our SKUs. Bottom line: multi-skin-type capability is a cost lever, not just a convenience.

Argument 3: "Gentle" is where the cheap quote breaks

I'm not a cosmetic chemist, so I can't tell you whether a specific surfactant blend is milder than another. That's a formulation question and I'd point you at someone who actually formulates. What I can tell you, from a procurement perspective, is how to price the difference between two blends across a year.

Because here's what I've watched happen. A gentle facial cleanser that isn't gentle doesn't fail in the lab. It fails in the complaint inbox, six weeks after launch, when the reviews start saying "my skin felt tight." Then you're not negotiating a unit price. You're negotiating a reformulation timeline while your launch budget burns.

One rework cost us somewhere in the low five figures, plus a six-week slip on a season. (Which, honestly, hurt more than the invoice.)

Looking back, I should have written testing and compatibility clauses into the contract before the first PO. At the time, the samples felt fine, the supplier was responsive, and I figured the paperwork could wait a cycle. It couldn't. Now every contract we sign has a testing schedule attached — no exceptions, no matter how good the samples feel.

What about the CFO who wants the lowest unit price?

Fair pushback. I've had that conversation twice. Two things made it easier.

First, the reliability premium is smaller than people assume. In our category it's usually 5–12% on unit price, not 50%. Show that number next to the cost of one reformulation and the conversation changes tone fast.

Second, I stopped arguing about price and started showing the math. One complaint wave, one reprint, one missed launch window — each of those costs more than a year of paying 8% more per unit. When you put it on a slide, nobody wants to be the person who chose the cheaper option and then explained the rework.

Now the counterargument I do accept: if you're ordering a 500-unit test run to validate a channel, the cheapest qualified supplier is probably the right call. TCO logic pays off at volume. At pilot volume, speed and flexibility matter more than a spreadsheet that's 80% blank.

The fundamentals didn't change. The invoice did.

I don't think total cost of ownership is a new idea. Procurement people have been preaching it since before I had this job. What changed is where the cost sits. In 2019, most of it was on the invoice. In 2025, a lot of it is in the testing schedule, the spec sheet, the MOQ structure, and the reformulation clause — none of which appear in a price column.

So no, I don't lead with price anymore when I evaluate a face cleanser sourcing partner. I lead with what the price includes, what it excludes, and who eats the difference when something goes wrong. If two suppliers can answer those three questions clearly, then — and only then — I look at the number at the bottom.

Prices and testing requirements vary by market and change often; verify current costs and regulatory expectations before you sign anything.